97 related articles for article (PubMed ID: 8164214)
1. Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study.
Yunus MB; Hussey FX; Aldag JC
J Rheumatol; 1993 Sep; 20(9):1557-60. PubMed ID: 8164214
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up.
Al-Allaf AW; Ottewell L; Pullar T
Clin Rheumatol; 2002 Nov; 21(6):472-7. PubMed ID: 12447630
[TBL] [Abstract][Full Text] [Related]
3. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction.
Dinerman H; Goldenberg DL; Felson DT
J Rheumatol; 1986 Apr; 13(2):368-73. PubMed ID: 3487650
[TBL] [Abstract][Full Text] [Related]
4. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
Kallenberg CG
Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
[TBL] [Abstract][Full Text] [Related]
5. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
6. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
7. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
8. An association of fibromyalgia with primary Sjögren's syndrome: a prospective study of 72 patients.
Bonafede RP; Downey DC; Bennett RM
J Rheumatol; 1995 Jan; 22(1):133-6. PubMed ID: 7699659
[TBL] [Abstract][Full Text] [Related]
9. Raynaud's phenomenon as an early sign of connective tissue diseases.
Kallenberg CG
Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
[TBL] [Abstract][Full Text] [Related]
10. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
[TBL] [Abstract][Full Text] [Related]
11. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
Tektonidou MG; Anapliotou M; Vlachoyiannopoulos P; Moutsopoulos HM
Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].
Ostuni P; Botsios C; Sfriso P; Bertagnin A; Cozzi F; Doria A; Todesco S
Minerva Med; 2002 Jun; 93(3):203-9. PubMed ID: 12094151
[TBL] [Abstract][Full Text] [Related]
13. [Soluble SS-A, SS-B and RNP antinuclear antigen antibodies in 66 cases of pure or associated forms of Gougerot-Sjögren syndrome].
Meyer O; Chabrand-Ahond L; Kahn MF; Ryckewaert A
Rev Rhum Mal Osteoartic; 1982 May; 49(6):421-5. PubMed ID: 6810443
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
[TBL] [Abstract][Full Text] [Related]
15. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
[TBL] [Abstract][Full Text] [Related]
16. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
[TBL] [Abstract][Full Text] [Related]
18. Women's health after plastic surgery.
Englert H; Joyner E; McGill N; Chambers P; Horner D; Hunt C; Makaroff J; O'Connor H; Russell N; March L
Intern Med J; 2001 Mar; 31(2):77-89. PubMed ID: 11480483
[TBL] [Abstract][Full Text] [Related]
19. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
Williams HJ; Alarcon GS; Joks R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; St Clair EW; Willkens RF; Yarboro C; Morgan JG; Egger MJ; Ward JR
J Rheumatol; 1999 Apr; 26(4):816-25. PubMed ID: 10229402
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.
Wollersheim H; Thien T; Hoet MH; Van Venrooy WJ
Eur J Clin Invest; 1989 Dec; 19(6):535-41. PubMed ID: 2515974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]